8 minute read
Jun. 5, 2022
2021 FDA Endocrinology Approvals: Novel Small Molecules Deep Dive
In 2021, the FDA approved two new drugs for endocrinology-related indications, including severe hypoglycemia in diabetes, and chronic kidney disease (CKD) associated with type 2 diabetes. This article and slide deck explores each in more detail, including but not limited to their:
target rationale
discovery
disease context
original patents
key clinical data
pharmacokinetics
industry history
Loading...